CBER to industry: Normal operations will resume in 2023 - Endpoints News
6/13/2022 12:00:00 AM2 years 10 months ago
by Zachary Brennan
by Zachary Brennan
The FDA's Center for Biologics Evaluation and Research (CBER) has devoted long hours to the pandemic, with marathon sessions churning out guidance documents and reviews within weeks when those tasks normally take months. But this Covid-19 work has come at the…
The FDA’s Center for Biologics Evaluation and Research (CBER) has devoted long hours to the pandemic, with marathon sessions churning out guidance documents and reviews within weeks when those tasks … [+764 chars]
full article...